<DOC>
	<DOCNO>NCT02096120</DOCNO>
	<brief_summary>The purpose study determine whether full mouth disinfection combination one week antibiotic amoxicillin plus metronidazole antibiotic therapy improve periodontitis disease activity rheumatoid arthritis .</brief_summary>
	<brief_title>Full Mouth Disinfection Antibiotics Periodontitis High Moderate Disease Activity Rheumatoid Arthritis</brief_title>
	<detailed_description>Rheumatoid arthritis ( RA ) currently incurable disease unknown origin characterize joint inflammation breakdown immune tolerance variety antigen , include citrullinated peptide generate peptidyl-arginine-deiminases ( PAD 's ) . Porphyromonas gingivalis ( P. g. ) derive PAD enzyme ( PPAD ) citrullinates preferentially C-terminal arginine residue , may generate P.g . derive gingipain protein ( Rgpb ) cleavage , several originate peptide sequence enolase , collagen , vimentin fibrinogen may cross-reactant citrullinated RA candidate autoantigens . Antigen-specific autoantibody RA may present year clinical disease onset arthritis , precise role initiation perpetuation characteristic articular immune process currently unclear . The situation autoantibodies similar poorly understood decade unanticipated reduction RA disease activity could achieve therapeutic B cell depletion use anti-CD20 therapy . While anti-CD20 therapy may affect regeneration autoantibody produce cell , investigator aim present study reduce potential oral trigger mechanism antigens cross-reactant autoreactive B cell plasma cell population . The study follow concept improve RA disease activity minimization inflammatory stimulus associate periodontitis , e.g . underlie microbial colonization , amount microbial foreign antigen , achieve standard oral hygienic mean , full mouth disinfection plus adjuvant short term antibiotic therapy establish periodontitis .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<criteria>Written inform consent Age 18 year old Diagnosis rheumatoid arthritis accord ACR/EULAR 2010 classification criterion plus serological , high titer ( &gt; 3x ULN ) rheumatoid factor CCP antibody titer Severe chronic periodontitis ( clinical attachment loss &gt; /= 5mm two separate location ) DAS 28 &gt; 4.2 screen inclusion ( within 28 day screen ) 1 two additional disease activity criterion : 1 . Synovial hyperplasia &gt; 22/66 point basis 22 joint , least 1/3 maximum score analyzes least select 5 joint interest OR 2 . Serum CRP &gt; 10 mg/l screen inclusion Stable dos &gt; =3 month , currently synthetic recombinant disease modify antirheumatic drug . If antiCD20 treatment : last rituximab infusion &gt; 90 day inclusion . Systemic corticosteroid &lt; = 10 mg stable least 14 day Nonsteroidalantirheumatic drug peripheral analgesic stable dos least 14 day Intolerance amoxicillin und azithromycin ( EBV infection , lymphatic leukemia , exanthema ) , general hypersensitivity betalactam antibiotic , intolerance metronidazole local anaesthesia Current intake allopurinol probenicid , oral anticoagulation , disulfiram , phenobarbital phenytoin , lithium ciclosporin Seizures Severe cardial electric conduction blockade Recent myocardial infraction instable coronary vessel disease , noncompensated myocardial insufficiency heart failure Noncompensated arterial hypertension Genetic cholinesterase deficiency General hemorrhagic diathesis intake oral anticoagulant Intake monoaminooxidase inhibitor tricyclic antidepressant Liver insufficiency Renal failure ( eGFR &lt; 30 ml/min ) Hemoglobin &lt; 10 g/dl Leukocytes &lt; 3/nl Neutrophils &lt; 1/nl Platelets &lt; 100/nl ALAT oder ASAT &gt; 3x ULN Pregnancy breastfeed Psychiatric condition could , opinion investigator , interfere compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Periodontitis</keyword>
</DOC>